Arlington Partners LLC Astrazeneca PLC Transaction History

Arlington Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$61.89 - $69.28 $26,117 - $29,236	422 New	422 $28,000
Q2 2023 Jul 26, 2023	BUY	$69.91 - $75.81 $24,538 - $26,609	351 Added 69.5%	856 $61,000
Q1 2023 Apr 26, 2023	BUY	$63.15 - $71.6 $5,241 - $5,942	83 Added 19.67%	505 $35,000
Q4 2021 Jan 18, 2022	BUY	$54.02 - $63.83 $22,796 - $26,936	422 New	422 $25,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.